Evidence map›Paper›PMID 23302786›Full record

ReviewVirulence2013

Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment?

Sanjay Bhattacharya

Open access · goldAbstract readReview
In one paragraph

Review in Virulence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Detection ofAnimals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Study of Colistin Resistant Gram Negative Organism in Hospitalized Patients: A Retrospective Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Development of a Magnetic Bead-Based Method for Specific Detection ofJournal of microbiology and biotechnology · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Frontiers in microbiology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Sanjay BhattacharyaConsultant Microbiologist, Tata Medical Center, Kolkata, India. drsanjay1970@hotmail.com
Tata Medical Center · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections with organisms that are resistant to various anti-microbial agents pose a serious challenge to effective management of infections. Resistance to antimicrobial agents, which may be intrinsic or acquired, has been noted in a wide variety of microorganisms causing human infections. These include resistance to antiviral agents in HIV, HBV, CMV and influenza virus, anti-parasitic agents in Plasmodium falciparum, anti-fungal agents in certain Candida species and MDR (multidrug-resistant) tuberculosis. It is however, the problem of multidrug-resistant bacterial infections (caused by MRSA, VRE, ESBL/AmpC/metallo-β lactamase producers and colistin-resistant Gram-negative bacilli) that has become a cause of major concern in clinical settings. Infections with these organisms can increase morbidity, mortality, increase the cost of therapy and increase the duration of hospitalization. The objective of this article is to review the question how early diagnosis of these infections, affects the overall management of infected or colonized patients, with regard to antimicrobial therapy.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial InfectionsCross InfectionEarly DiagnosisHumansSurvival AnalysisTreatment OutcomeAnti-Bacterial Agentsantimicrobial therapycarbapenem resistanceearly diagnosisESBLinfection controlMDROs (multi-drug resistant organisms)MRSAPCRsurveillance cultureVRE

Identifiers

PMID23302786
PMCPMC3654618
OpenAlexW2008958871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.